Tag: Phase3Trial

Browse exclusive Tags!

Vera Therapeutics’ Atacicept Receives FDA Breakthrough Therapy Status for IgA Nephropathy, US

Vera Therapeutics' Atacicept granted FDA Breakthrough Therapy status for IgA nephropathy, showing promising results in Phase 2b trial.

Popular

Subscribe

spot_imgspot_img